Out-Licensing Opportunity

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Licensing Partners Identification for client’s proprietary technology based neonatal MSCsOpportunity Assessment through Secondary & Primary Intelligence.

Problem Statement:

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from across the globe. They wished to identify a potential list of companies, to become a fit for their neonatal high quality MSCs and can prove to be a good business partner as a licensee for their proprietary “API” of the stem cell therapy domain.

Our Methodology:
  • Stem Cell Market Assessment
  • Companies Assessment Portfolio Assessment
  • Deal/Investment Assessment
  • Interest in Client’s MSC
  • 20 Potential Partners
Results:
  • Matrix Analysis positioned the top 20 companies researched.
  • The client could assess the Top companies which would effectively fit their strategic needs and objectives (the TARGET quadrant).
  • DelveInsight fixed meetings with these probably 4-5 companies for the client to take discussions forward.

Related Insights

Mergers and Acquisitions
Mergers and Acquisitions

A large medical device client, based in the United States with capabilities in drug delivery medical devices, [...]

View Case
Product Assessment
Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case
R&D Analysis
R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.